Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16525184
[patent_doc_number] => 20200399264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/902080
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 509
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902080 | 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS | Jun 14, 2020 | Abandoned |
Array
(
[id] => 16343461
[patent_doc_number] => 20200308111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => Cationic Lipid
[patent_app_type] => utility
[patent_app_number] => 16/897752
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897752 | Cationic lipid | Jun 9, 2020 | Issued |
Array
(
[id] => 16483918
[patent_doc_number] => 20200377519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HEPATITIS B ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/891401
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891401 | Hepatitis B antiviral agents | Jun 2, 2020 | Issued |
Array
(
[id] => 16885275
[patent_doc_number] => 20210171470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/888484
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888484 | Compounds and methods for the targeted degradation of androgen receptor | May 28, 2020 | Issued |
Array
(
[id] => 16468157
[patent_doc_number] => 20200369694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES
[patent_app_type] => utility
[patent_app_number] => 15/930756
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930756
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930756 | NOVEL CATALYSTS FOR THE SYNTHESIS OF OLIGOMERIC ISOCYANATES | May 12, 2020 | Abandoned |
Array
(
[id] => 16696633
[patent_doc_number] => 10947213
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-16
[patent_title] => TLR7/8 antagonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/929348
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95014
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15929348
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/929348 | TLR7/8 antagonists and uses thereof | Apr 27, 2020 | Issued |
Array
(
[id] => 16570568
[patent_doc_number] => 20210009574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Amine derivative and an organic electroluminescent device thereof
[patent_app_type] => utility
[patent_app_number] => 16/848401
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848401 | Amine derivative and an organic electroluminescent device thereof | Apr 13, 2020 | Issued |
Array
(
[id] => 16290053
[patent_doc_number] => 10766888
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-09-08
[patent_title] => HMOX1 inducers
[patent_app_type] => utility
[patent_app_number] => 16/843426
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 56271
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843426 | HMOX1 inducers | Apr 7, 2020 | Issued |
Array
(
[id] => 18153039
[patent_doc_number] => 11565999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Methods of synthesizing aztreonam derivatives
[patent_app_type] => utility
[patent_app_number] => 16/840675
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28977
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840675 | Methods of synthesizing aztreonam derivatives | Apr 5, 2020 | Issued |
Array
(
[id] => 18389949
[patent_doc_number] => 20230158167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => SITE-SPECIFIC ANTIBODY CONJUGATION AND ANTIBODY-DRUG CONJUGATE AS SPECIFIC EMBODIMENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/980503
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980503 | SITE-SPECIFIC ANTIBODY CONJUGATION AND ANTIBODY-DRUG CONJUGATE AS SPECIFIC EMBODIMENT THEREOF | Mar 8, 2020 | Pending |
Array
(
[id] => 16360870
[patent_doc_number] => 20200317621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/813230
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813230 | POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-ETHYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF | Mar 8, 2020 | Abandoned |
Array
(
[id] => 16756542
[patent_doc_number] => 10975078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Fused indazole pyridone compounds as antivirals
[patent_app_type] => utility
[patent_app_number] => 16/808985
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42025
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808985 | Fused indazole pyridone compounds as antivirals | Mar 3, 2020 | Issued |
Array
(
[id] => 16792902
[patent_doc_number] => 20210122719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => Method For Preparing Aryl 2-Tetrazol-1-Yl Keto With Improved Selectivity
[patent_app_type] => utility
[patent_app_number] => 16/803039
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/803039 | Method for preparing aryl 2-tetrazol-1-yl keto with improved selectivity | Feb 26, 2020 | Issued |
Array
(
[id] => 16297726
[patent_doc_number] => 20200283449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SOLID FORMS OF AN ANTIVIRAL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/797793
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797793 | Solid forms of an antiviral compound | Feb 20, 2020 | Issued |
Array
(
[id] => 17490422
[patent_doc_number] => 11279711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases
[patent_app_type] => utility
[patent_app_number] => 16/795884
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24076
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 595
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795884
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795884 | Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases | Feb 19, 2020 | Issued |
Array
(
[id] => 17513665
[patent_doc_number] => 11292794
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => 3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same
[patent_app_type] => utility
[patent_app_number] => 16/791715
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 81
[patent_no_of_words] => 82602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791715 | 3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same | Feb 13, 2020 | Issued |
Array
(
[id] => 17014084
[patent_doc_number] => 11083703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Prodrugs of fumarates and their use in treating various diseases
[patent_app_type] => utility
[patent_app_number] => 16/790849
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20769
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790849 | Prodrugs of fumarates and their use in treating various diseases | Feb 13, 2020 | Issued |
Array
(
[id] => 16549683
[patent_doc_number] => 10882832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Bicyclic heteroaryl derivatives and preparation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/791243
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 25436
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791243 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Feb 13, 2020 | Issued |
Array
(
[id] => 16012627
[patent_doc_number] => 20200181156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CARBOXY TETRAHYDROPYRAZOLOPYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/790400
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790400 | CARBOXY TETRAHYDROPYRAZOLOPYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES | Feb 12, 2020 | Abandoned |
Array
(
[id] => 16977557
[patent_doc_number] => 20210221794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => ISATIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/747297
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747297 | ISATIN DERIVATIVES | Jan 19, 2020 | Abandoned |